Psychedelics like psilocybin, DMT, and LSD are increasingly
welcomed in behavioral and psychiatric research, with
implications that extend well beyond neuroscience. This
webinar will delve into efforts to transform anecdotal evidence
into supported medical interventions through systematic
research and controlled clinical trials.
Speaker Information:
David Nutt, DM, FRCP, FRCPSYCH, FSB, FMEDSCI
Professor, Neuropsychopharmacology Unit
Centre for Psychiatry
Imperial College London
Psychopharmacology: From Principle to Practice.
An introduction to Drug Science’s Medical Psychedelics Working Group.
Interested in sponsoring a webinar?
Click here to contact our friendly sales team.
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2021 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy